Nuvectis Pharma, Inc. NVCT Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Nuvectis Pharma, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s earnings yield?
- Nuvectis Pharma, Inc. (NVCT) reported earnings yield of -13.3% in Q1 2026.
- How has Nuvectis Pharma, Inc.'s earnings yield changed year-over-year?
- Nuvectis Pharma, Inc.'s earnings yield decreased by 50.3% year-over-year, from -8.8% to -13.3%.
- What is the long-term trend for Nuvectis Pharma, Inc.'s earnings yield?
- Over 3 years (2022 to 2025), Nuvectis Pharma, Inc.'s earnings yield has grown at a -7.7% compound annual growth rate (CAGR), from -17.4% to -13.7%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.